Medicare lab CPT code with covered diagnosis

Laboratory National Coverage Determinations included for Laboratory Customers

CPT	Policy Number	Title	Original Effective Date	Last Revised
80061	190.23	Lipids Testing	11/25/2002	10/1/2009
80074	190.33	Hepatitis Panel/Acute Hepatitis Panel	11/25/2002	10/1/2009
80162	190.24	Digoxin Therapeutic Drug Assay	11/25/2002	10/1/2009
82105	190.25	Alpha-fetoprotein	11/25/2002	10/1/2009
82270	190.34	Fecal Occult Blood Test	11/25/2002	7/1/2008
82272	190.34	Fecal Occult Blood Test	11/25/2002	10/1/2009
82378	190.26	Carcinoembryonic Antigen	11/25/2002	10/1/2009
82465	190.23	Lipids Testing	11/25/2002	10/1/2009
82523	190.19	Collagen Crosslinks, Any Method	11/25/2002
82728	190.18	Serum Iron Studies	11/25/2002	1/1/2010
82947	190.2	Blood Glucose Testing	11/25/2002	4/1/2009
82948	190.2	Blood Glucose Testing	11/25/2002	4/1/2009
82962	190.2	Blood Glucose Testing	11/25/2002	4/1/2009
82977	190.32	Gamma Glutamyl Transferase	11/25/2002	1/1/2010
82985	190.21	Glycated Hemoglobin/Glycated Protein	11/25/2002	1/1/2009
83036	190.21	Glycated Hemoglobin/Glycated Protein	11/25/2002	1/1/2009
83540	190.18	Serum Iron Studies	11/25/2002	1/1/2010
83550	190.18	Serum Iron Studies	11/25/2002	1/1/2010
83700	190.23	Lipids Testing	11/25/2002	10/1/2009
83701	190.23	Lipids Testing	11/25/2002	10/1/2009
83704	190.23	Lipids Testing	11/25/2002	10/1/2009
83718	190.23	Lipids Testing	11/25/2002	10/1/2009
83721	190.23	Lipids Testing	11/25/2002	10/1/2009
84153	190.31	Prostate Specific Antigen	11/25/2002	10/1/2008
84436	190.22	Thyroid Testing	11/25/2002	10/1/2009
84439	190.22	Thyroid Testing	11/25/2002	10/1/2009
84443	190.22	Thyroid Testing	11/25/2002	10/1/2009
84466	190.18	Serum Iron Studies	11/25/2002	1/1/2010
84478	190.23	Lipids Testing	11/25/2002	10/1/2009
84479	190.22	Thyroid Testing	11/25/2002	10/1/2009
84702	190.27	Human Chorionic Gonadotropin	11/25/2002	1/1/2007
85004	190.15	Blood Counts	11/25/2002	7/1/2008
85007	190.15	Blood Counts	11/25/2002	7/1/2008
85008	190.15	Blood Counts	11/25/2002	7/1/2008
85013	190.15	Blood Counts	11/25/2002	7/1/2008
85014	190.15	Blood Counts	11/25/2002	7/1/2008
85018	190.15	Blood Counts	11/25/2002	7/1/2008
85025	190.15	Blood Counts	11/25/2002	7/1/2008
85027	190.15	Blood Counts	11/25/2002	7/1/2008
85032	190.15	Blood Counts	11/25/2002	7/1/2008
85048	190.15	Blood Counts	11/25/2002	7/1/2008
85049	190.15	Blood Counts	11/25/2002	7/1/2008
85610	190.17	Prothrombin Time (PT)	11/25/2002	10/1/2009
85730	190.16	Partial Thromboplastin Time (PTT)	11/25/2002	10/1/2009
86300	190.29	Tumor Antigen by Immunoassay CA 15-3/CA 27.29	11/25/2002	10/1/2006
86301	190.3	Tumor Antigen by Immunoassay CA 19-9	11/25/2002	10/1/2006
86304	190.28	Tumor Antigen by Immunoassay CA 125	11/25/2002	10/10/2006
86689	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
86701	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
86702	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
86703	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87086	190.12	Urine Culture, Bacterial	11/25/2002	10/1/2009
87088	190.12	Urine Culture, Bacterial	11/25/2002	10/1/2009
87390	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87391	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87534	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87535	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87536	190.13	Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)	11/25/2002	10/1/2008
87537	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87538	190.14	Human Immunodeficiency Virus (HIV) Testing (Diagnosis)	11/25/2002	1/1/2009
87539	190.13	Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)	11/25/2002	10/1/2008
G0103	210.1	Prostate Cancer Screening Tests	11/25/2002
G0123	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002
G0124	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0141	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0143	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0144	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0145	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0147	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0148	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
G0248	190.11	Home Prothrombin Time INR Monitoring for Anticoagulation Management	11/25/2002	3/19/2008
G0249	190.11	Home Prothrombin Time INR Monitoring for Anticoagulation Management	11/25/2002	3/19/2008
G0250	190.11	Home Prothrombin Time INR Monitoring for Anticoagulation Management	11/25/2002	3/19/2008
G0328	210.3	Colorectal Cancer Screening Tests	11/25/2002
P3000	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
P3001	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007
Q0091	210.2	Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer	11/25/2002	4/1/2007